Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared a post on LinkedIn:
“Pleased to share our latest International Bladder Cancer Group (IBCG) consensus on the optimal management of muscle-invasive bladder cancer in European Urology.
This multidisciplinary collaboration brought together global experts and patient advocates to provide practical guidance for everything related to MIBC from diagnosis to point-of-care decision-making and modern clinical trial design considerations in MIBC.”
Title: Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group
Authors: Shilpa Gupta, Roger Li, Patrick J. Hensley, Siamak Daneshmand, Bishoy M. Faltas, Petros Grivas, Niyati Lobo, Maria Carmen Mir, Joshua J. Meeks, Kent W. Mouw, Marco Moschini, Andrea Necchi, Karima Oualla, Kamal S. Pohar, Jonathan E. Rosenberg, Bogdana Schmidt, Arlene O. Siefker-Radtke, Gary D. Steinberg, Arnulf Stenzl, Roger J. Buckley, Ashish M. Kamat
Read The Full Article
Other articles about Bladder Cancer on OncoDaily.